Search

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

A breakthrough in transgenic mice opens the door to “Humabodies.”

Crystallization is often the ultimate step of a drug substance manufacturing process prior to isolation and drying.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

How can we achieve gender parity in drug dosing?

We speak with Laertis Ikonomou and Dan Weiss about the ISCT's work to combat unproven cell therapies.

Queenie Jang reveals how the ISCT created an interactive virtual conference in under two months.

What challenges and opportunities do immunotherapy developers face?

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…

The UK’s medicines regulator releases new guidance for Brexit.